Contact Shane, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackShane Schaffer is the Co-founder, Chairman, and Chief Executive Officer of Cingulate Therapeutics, a Phase 3 clinical-stage biopharmaceutical company headquartered in Kansas City, Kansas. This enterprise focuses on developing several branded next-generation pharmaceutical products, mainly targeting Attention Deficit/Hyperactivity Disorder (ADHD), anxiety disorders, and insomnia.
With 25 years of experience in the pharmaceutical sector, he specializes in drug development and commercialization. H…